EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Anti-staphylococcal fatty acids: mode of action, bacterial resistance and implications for therapeutic application

Edward J A Douglas, Nathanael Palk, Emily R Rudolph, Maisem Laabei

Microbiology · 22.05.2025 · 171 (5)

DOI: 10.1099/mic.0.001563 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microbiology, erschienen am 22.05.2025. Verfasst von Edward J A Douglas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Bacterial Resistance Biology, Imperial College London, London W2 1NY, UK. Hauptthemen laut MEDLINE: Fatty Acids, Anti-Bacterial Agents, Staphylococcal Infections, Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council, Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Novel strategies to counter multidrug-resistant pathogens such as methicillin-resistant Staphylococcus aureus are urgently required. The antimicrobial properties of fatty acids (FAs) have long been recognized and offer significant promise as viable alternatives to, or potentiators of, conventional antibiotics. In this review, we examine the interplay between FAs and S. aureus , specifically detailing the underlying molecular mechanisms responsible for FA-mediated inhibition and the counteracting staphylococcal systems evolved to withstand FA onslaught. Finally, we present an update on the recent therapeutic FA applications to combat S. aureus infection, either as a monotherapy or in combination with antibiotics or host-derived antimicrobial peptides. Given the frequency of interaction between FAs and S. aureus during host colonization and infection, understanding FA mode of action and deciphering S. aureus FA resistance strategies are central in rationally designing future anti-staphylococcal FAs and FA-combination therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty AcidsAnti-Bacterial AgentsStaphylococcal InfectionsMethicillin-Resistant Staphylococcus aureusStaphylococcus aureusDrug Resistance, BacterialHumans

Stichwörter der Autor:innen

Staphylococcus aureusfatty acidsmode of actionresistance mechanismstherapeutics

Substanzen

Fatty AcidsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Centre for Bacterial Resistance Biology, Imperial College London, London W2 1NY, UK.
  • School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
  • Department of Life Sciences, University of Bath, Bath BA2 7AY, UK.

Förderung

  • Engineering and Physical Sciences Research Council
  • Academy of Medical Sciences

Zitieren

APA

Douglas, E. J. A., Palk, N., Rudolph, E. R., & Laabei, M. (2025). Anti-staphylococcal fatty acids: mode of action, bacterial resistance and implications for therapeutic application. Microbiology, 171(5). https://doi.org/10.1099/mic.0.001563

Vancouver

Douglas EJA, Palk N, Rudolph ER, Laabei M. Anti-staphylococcal fatty acids: mode of action, bacterial resistance and implications for therapeutic application. Microbiology. 2025;171(5). doi:10.1099/mic.0.001563

BibTeX
@article{Douglas2025,
  author = {Douglas, Edward J A and Palk, Nathanael and Rudolph, Emily R and Laabei, Maisem},
  title = {Anti-staphylococcal fatty acids: mode of action, bacterial resistance and implications for therapeutic application},
  journal = {Microbiology},
  year = {2025},
  volume = {171},
  number = {5},
  doi = {10.1099/mic.0.001563}
}
Kostenlos starten →